Guardant Health GH 深 沪
等待开盘 05-18 09:30:00 美东时间
94.92
-3.740
-3.79%
华盛通- 最 高98.00
- 今 开97.31
- 成交量 177.13万股
- 最 低 92.50
- 昨 收 98.66
- 总市值 125.86亿
- 52周最高 120.74
- 市盈率 静 --
- 换手率 1.34%
- 52周最低 37.73
- 委 比 66.80%
- 总股本 1.33亿
- 历史最高 181.07
- 量 比 0.83
- 振 幅 5.57%
- 历史最低 15.81
- 每 手 1
- 风险率 23.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Guardant Health CMO resigns
Guardant Health Chief Medical Officer Craig Eagle has resigned from the company, effective Friday. An SEC filing did not indicate the reasons for his departure, nor who his replacement is. Eagle prev...
05-08 23:49
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson May 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, McDonald's and McKesson on Friday. HIGHLIGHTS * Applied Materials Inc AMAT.O : Berenb
05-08 15:12
财报速睇 | Guardant Health 2026财年Q1营收3.02亿美元，同比增长48.3%；归母净利润亏损1.12亿美元，同比亏损扩大17.8%
华盛资讯5月8日讯，Guardant Health公布2026财年Q1业绩，公司Q1营收3.02亿美元，同比增长48.3%，归母净利润亏损1.12亿美元，同比亏损扩大17.8%。
05-08 09:22
财报速睇 | Guardant Health 2026财年Q1营收3.02亿美元，同比增长48.3%；归母净利润亏损1.12亿美元，同比亏损扩大17.8%
华盛资讯5月8日讯，Guardant Health公布2026财年Q1业绩，公司Q1营收3.02亿美元，同比增长48.3%，归母净利润亏损1.12亿美元，同比亏损扩大17.8%。
05-08 06:02
Guardant Health shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY2026 sales guidance above estimates.
Guardant Health shares are trading higher after the company reported better-tha...
05-08 05:20
Guardant Health Raises FY2026 Sales Guidance from $1.250B-$1.280B to $1.300B-$1.320B vs $1.271B Est
2026 GuidanceGuardant Health now expects full year 2026 revenue to be in the range of $1.30 to $1.32 billion, representing growth of 32% to 34% compared to full year 2025. This compares to the prior range of $1.25 to
05-08 04:08
William Blair updates conviction stock list
William Blair updated its 2026 conviction stock list, swapping in three new names. Additions Somnigroup International Inc. (SGI): Added to the Consumer sector by analyst Phillip Blee. The rationale is...
05-04 18:37
Pfizer, Arvinas breast cancer therapy approved by the FDA
The U.S. Food and Drug Administration on Friday approved vepdegestrant, a breast cancer therapy developed by Pfizer (PFE) and Arvinas (ARVN) under the brand name Veppanu. Accordingly, the once-daily o...
05-02 00:47
